Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
An update from Astrana Health ( (ASTH) ) is now available.
Astrana Health reported record 2025 results on March 2, 2026, with total revenue rising 56% to $3.18 billion, driven mainly by its Care Partners segment, while adjusted EBITDA increased 21% to $205.4 million and free cash flow reached $104.5 million; fourth‑quarter revenue climbed 43% to $950.5 million and adjusted EBITDA 50% to $52.5 million. The company disclosed a material weakness in internal controls related to acquisition and purchase accounting processes and will use a 15‑day extension for its 2025 Form 10‑K filing, but said the issue does not involve any material misstatement, and its board doubled the share repurchase authorization to $100 million after buying 633,844 shares in the fourth quarter, signaling confidence in cash generation and capital return capacity despite the control issue.
The most recent analyst rating on (ASTH) stock is a Hold with a $24.00 price target. To see the full list of analyst forecasts on Astrana Health stock, see the ASTH Stock Forecast page.
Spark’s Take on ASTH Stock
According to Spark, TipRanks’ AI Analyst, ASTH is a Neutral.
ASTH scores as a balanced risk/reward: strong top-line expansion and positive earnings-call execution/integration are outweighed by sharp margin compression, higher leverage and weaker free cash flow trends. Technicals support the uptrend but appear overextended, while the very high P/E meaningfully drags the score.
To see Spark’s full report on ASTH stock, click here.
More about Astrana Health
Astrana Health, Inc., based in Alhambra, Calif., is a physician‑centric, technology‑powered, risk‑bearing healthcare management company that enables providers to deliver accessible, high‑quality, value‑based care across payer types. The Nasdaq‑listed group operates through Care Partners, Care Delivery and Care Enablement segments, leveraging a fully delegated, payer‑agnostic model and an AI‑enabled clinical platform to manage costs and outcomes.
Average Trading Volume: 531,731
Technical Sentiment Signal: Sell
Current Market Cap: $1.02B
See more insights into ASTH stock on TipRanks’ Stock Analysis page.